About us

History

1988

founding of curasan® Pharma GmbH
launch of local anaesthetics
market introduction of antibiotics

1996

founding of curasan® Benelux

1997

registration of Cerasorb® for dentistry and maxillofacial surgery

1998

start of clinical studies with Cerasorb®
launch of Hy-GAG®
founding of liaison office Austria

1999

first clinical results on Cerasorb®
founding of curasan branch in France
launch of a method for the production of platelet rich plasma (PRP) from patient blood

2000

Innovation Award for Cerasorb®
transformation into a public company (curasan AG ) and Initial Public Offering (IPO)

2001

acquisition of Titanium Innovations
acquisition of Pro-tec Medizinische Produkte GmbH
launch of stypro®
upgrading of R&D and production center in Frankfurt

2002

FDA-approval for Cerasorb® Ortho™ for use in orthopedics and traumatology
CE-approval for Cerasorb® block forms

2003

Product launch of Cerasorb® Ortho™ in the USA
FDA-approval of Cerasorb® block forms in the USA
FDA-certification of Cerasorb® production site
Sale of pharmaceuticals business

2004

founding of curasan, Inc., USA
product launch of Cerasorb® M
merging of GerontoCare and Titanium Innovations GmbH with curasan AG

2005

product launch Curavisc® (curasan Benelux)

2006

product launch REVOIS® All-in-One Implant System

2008

Sale of dental division to RIEMSER ARZNEITMITTEL AG